An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Columbia Care to Report Second Quarter 2022 Results on August 15, 2022
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Columbia Care Inc. (CCHWF) announces it will report 2Q financial results on August 15, 2022, before U.S. markets open. The company will host a conference call at 8:00 a.m. EST to discuss these results. Interested participants must pre-register for the call, with details available on their website. Columbia Care is one of the largest cannabis providers in the U.S., operating 131 facilities, including 99 dispensaries and 32 cultivation sites. The firm serves both medical and adult-use markets, offering a range of cannabis products and operating under the Cannabist retail brand.
Positive
None.
Negative
None.
NEW YORK--(BUSINESS WIRE)--
Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”) today announced that it will report its financial results for the second quarter ended June 30, 2022 before U.S. financial markets open on Monday, August 15, 2022. Following the release of financial results, Company management will conduct a conference call at 8:00 a.m. EST to discuss financial and operating results for the second quarter of 2022.
A replay of the audio webcast will be available in the Investor Relations section of the Company’s website approximately 2 hours after completion of the call and will be archived for 30 days.
About Columbia Care
Columbia Care is one of the largest and most experienced cultivators, manufacturers and providers of cannabis products and related services, with licenses in 18 U.S. jurisdictions and the EU. Columbia Care operates 131 facilities including 99 dispensaries and 32 cultivation and manufacturing facilities, including those under development. Columbia Care is one of the original multi-state providers of medical cannabis in the U.S. and now delivers industry-leading products and services to both the medical and adult-use markets. In 2021, the company launched Cannabist, its new retail brand, creating a national dispensary network that leverages proprietary technology platforms. The company offers products spanning flower, edibles, oils and tablets, and manufactures popular brands including Seed & Strain, Triple Seven, gLeaf, Classix, Press, Amber and Platinum Label CBD. For more information on Columbia Care, please visit https://columbia.care.